Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 7/20 | 0.64 |
| ▸ | NLN | Q9BYT8 | 1/20 | 0.64 |
| ▸ | MMP1 | P03956 | 4/20 | 0.55 |
| ▸ | MMP9 | P14780 | 3/20 | 0.55 |
| ▸ | MMP8 | P22894 | 3/20 | 0.55 |
| ▸ | MMP3 | P08254 | 2/20 | 0.55 |
| ▸ | NMBR | P28336 | 4/20 | 0.54 |
| ▸ | MMP2 | P08253 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12228541 | 1.00 | GHSR (0.64) | GHSRNLNMMP1MMP9MMP8 | |
| SCHEMBL21641790 | 0.90 | NLN (0.66) | GHSRNLNNMBR | |
| SCHEMBL29479454 | 0.90 | GHSR (0.67) | GHSRNLNNMBR | |
| SCHEMBL14279286 | 0.89 | GHSR (0.64) | GHSRNLN | |
| SCHEMBL18862458 | 0.87 | GHSR (0.70) | GHSRNLN | |
| SCHEMBL12202834 | 0.87 | GHSR (0.68) | GHSR | |
| SCHEMBL21641789 | 0.86 | NLN (0.69) | GHSRNLNNMBR | |
| SCHEMBL12202957 | 0.85 | NLN (0.52) | GHSRNLNMMP1MMP9MMP8 | |
| SCHEMBL18857368 | 0.85 | GHSR (0.66) | GHSRNLN | |
| SCHEMBL2183813 | 0.84 | OPRM1 (0.61) | GHSRMMP1MMP9MMP8MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | EPIX PHARMACEUTICALS, INC. | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293656-A1 | COLLAGEN BINDING PEPTIDES | COL14A1, COL2A1, COL1A1 | GHSR 2894/4885NLN 1529/4885MMP1 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.